Clinical interpretation of reference intervals and reference limits. A plea for assay harmonization

George G. Klee

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Reference intervals for healthy subjects and diseased populations are important benchmarks for the clinical interpretation of laboratory test values. It is important that the testing conditions used to collect the reference data be closely matched with the testing conditions used for patient data. Interlaboratory differences and intralaboratory changes, especially changes in analytic set-points, can markedly affect the clinical interpretation of tests. If laboratory testing methods could be harmonized, laboratories could potentially share reference data to make these data more reliable. This chapter illustrates the use of reference intervals for healthy subjects and reference data from diseased populations for medical decisions. One example illustrates the effects of age differences on test result interpretation. Other examples illustrate use of thyroid-stimulating hormone (TSH) and combinations of TSH with free thyroxine measurements for diagnosing thyroid diseases. Both univariate and multivariate reference intervals are discussed. Model systems for using disease prevalence and cost utility functions are provided to illustrate optimization of medical decisions.

Original languageEnglish (US)
Pages (from-to)752-757
Number of pages6
JournalClinical Chemistry and Laboratory Medicine
Volume42
Issue number7
DOIs
StatePublished - 2004

Fingerprint

Assays
Thyrotropin
Healthy Volunteers
Testing
Benchmarking
Cost of Illness
Thyroid Diseases
Thyroxine
Population
Costs

Keywords

  • Decision limits
  • Harmonization
  • Normal values
  • Reference intervals
  • Reference limits

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Clinical interpretation of reference intervals and reference limits. A plea for assay harmonization. / Klee, George G.

In: Clinical Chemistry and Laboratory Medicine, Vol. 42, No. 7, 2004, p. 752-757.

Research output: Contribution to journalArticle

@article{baead34a99984b5896f52c4b4b3d2713,
title = "Clinical interpretation of reference intervals and reference limits. A plea for assay harmonization",
abstract = "Reference intervals for healthy subjects and diseased populations are important benchmarks for the clinical interpretation of laboratory test values. It is important that the testing conditions used to collect the reference data be closely matched with the testing conditions used for patient data. Interlaboratory differences and intralaboratory changes, especially changes in analytic set-points, can markedly affect the clinical interpretation of tests. If laboratory testing methods could be harmonized, laboratories could potentially share reference data to make these data more reliable. This chapter illustrates the use of reference intervals for healthy subjects and reference data from diseased populations for medical decisions. One example illustrates the effects of age differences on test result interpretation. Other examples illustrate use of thyroid-stimulating hormone (TSH) and combinations of TSH with free thyroxine measurements for diagnosing thyroid diseases. Both univariate and multivariate reference intervals are discussed. Model systems for using disease prevalence and cost utility functions are provided to illustrate optimization of medical decisions.",
keywords = "Decision limits, Harmonization, Normal values, Reference intervals, Reference limits",
author = "Klee, {George G.}",
year = "2004",
doi = "10.1515/CCLM.2004.127",
language = "English (US)",
volume = "42",
pages = "752--757",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "7",

}

TY - JOUR

T1 - Clinical interpretation of reference intervals and reference limits. A plea for assay harmonization

AU - Klee, George G.

PY - 2004

Y1 - 2004

N2 - Reference intervals for healthy subjects and diseased populations are important benchmarks for the clinical interpretation of laboratory test values. It is important that the testing conditions used to collect the reference data be closely matched with the testing conditions used for patient data. Interlaboratory differences and intralaboratory changes, especially changes in analytic set-points, can markedly affect the clinical interpretation of tests. If laboratory testing methods could be harmonized, laboratories could potentially share reference data to make these data more reliable. This chapter illustrates the use of reference intervals for healthy subjects and reference data from diseased populations for medical decisions. One example illustrates the effects of age differences on test result interpretation. Other examples illustrate use of thyroid-stimulating hormone (TSH) and combinations of TSH with free thyroxine measurements for diagnosing thyroid diseases. Both univariate and multivariate reference intervals are discussed. Model systems for using disease prevalence and cost utility functions are provided to illustrate optimization of medical decisions.

AB - Reference intervals for healthy subjects and diseased populations are important benchmarks for the clinical interpretation of laboratory test values. It is important that the testing conditions used to collect the reference data be closely matched with the testing conditions used for patient data. Interlaboratory differences and intralaboratory changes, especially changes in analytic set-points, can markedly affect the clinical interpretation of tests. If laboratory testing methods could be harmonized, laboratories could potentially share reference data to make these data more reliable. This chapter illustrates the use of reference intervals for healthy subjects and reference data from diseased populations for medical decisions. One example illustrates the effects of age differences on test result interpretation. Other examples illustrate use of thyroid-stimulating hormone (TSH) and combinations of TSH with free thyroxine measurements for diagnosing thyroid diseases. Both univariate and multivariate reference intervals are discussed. Model systems for using disease prevalence and cost utility functions are provided to illustrate optimization of medical decisions.

KW - Decision limits

KW - Harmonization

KW - Normal values

KW - Reference intervals

KW - Reference limits

UR - http://www.scopus.com/inward/record.url?scp=4344648887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344648887&partnerID=8YFLogxK

U2 - 10.1515/CCLM.2004.127

DO - 10.1515/CCLM.2004.127

M3 - Article

C2 - 15327010

AN - SCOPUS:4344648887

VL - 42

SP - 752

EP - 757

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 7

ER -